Exploration of sex differences in Rhes effects in dopamine mediated behaviors by Quintero, Gabriel C & Spano, Daniela
© 2011 Quintero and Spano, publisher and licensee Dove Medical Press Ltd.   This is an Open Access article   
which permits unrestricted noncommercial use, provided the original work is properly cited.
Neuropsychiatric Disease and Treatment 2011:7 697–706
Neuropsychiatric Disease and Treatment Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
697
OrigiNAL reSeArch
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/NDT.S25888
exploration of sex differences in rhes effects  
in dopamine mediated behaviors
gabriel c Quintero1,2  
Daniela Spano3
1iNDicASAT AiP, centro de 
Neurociencias, Panamá, 2Department 
of Psychology, University of New 
Orleans, N Orleans, Louisiana, USA; 
3ceiNge Biotechnologie Avanzate, 
Naples, italy
correspondence: gabriel c Quintero 
iNDicASAT AiP, centro de 
Neurociencias, #219 clayton,  
ciudad del Saber, Panamá 
Tel +507 397 9772 
Fax +507 397 9772 
email gquintero2008@gmail.com
Abstract: Studies have shown that Ras homolog enriched in striatum (Rhes) proteins are highly 
expressed in areas of the central nervous system that have high dopaminergic innervation. In this 
study, we used Rhes mutant mice (Wild type, Rhes KO, Rhes Heterozygous) of both sexes to 
explore differences in the effects of Rhes protein levels in basal levels of activity, anxiety, and 
stereotypy, in relation to sex. Adult male and female mice were evaluated in an open field test 
for measuring basal levels of activity and anxiety for 5 consecutive days, and they were tested 
in the apomorphine-induced stereotypy paradigm. Rhes protein levels affected basal levels 
of activity but it was not found to be related to sex differences. Moreover, a decrease in Rhes 
protein levels was linked to a nonsignificant anxiolytic effect, mainly in female mice. Finally, a 
decrease in Rhes protein levels does not affect dopamine D1 and D2 receptor (D1/D2) synergism 
in female or male mice. Together, these results suggest that Rhes protein levels affect   locomotion 
activity, and have an influence in anxiety depending on sex; Rhes protein levels do not affect 
D1/D2 synergism in both sexes.
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Introduction
Dopamine (DA) is a catecholamine that serves as a major neurotransmitter, mediating 
diverse behaviors like movement, attention, motivation, and cognition.1 DA   receptors 
are normally divided in D1 and D2 subfamilies. The D1 subfamily is composed 
of the D1 and D5 subtypes, and the D2 subfamily composed of the D2, D3, and D4 
subtypes.2 Under normal conditions, the majority of motor behaviors are mediated by 
the combined action of the D1 and D2 subtypes rather than the other subtypes.3,4 This 
combined action of D1 and D2 subtypes is known as D1/D2 receptor synergism.5,6 The 
D1/D2 receptor synergism has been supported empirically by studies at   different levels: 
behavioral, electrophysiological, and gene expression in the striatum.6–10 However, the 
mechanism subjacent to this synergism has not been discovered. In order to explain 
this, it is necessary to elucidate the distribution of D1 and D2 receptors at the level of the 
striatum, but this has remained theoretically controversial; in effect, information on this 
topic is complicated. Theories range from complete colocalization to total segregation 
in striatal neurons.11 Interaction of D1 and D2 receptors subserving   synergism could 
be intercellular, intracellular, or combination of both.
Furthermore, DA receptors are functionally dynamic, altering their sensitivity 
to agonists in response to changes in the extracellular environment. For instance, 
following depletion of endogenous DA by means of selective destruction of 
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breakdown in D1/D2 synergism.12,13 This breakdown in 
D1/D2   synergism can also be generated by treatment with 
reserpine, a   catecholamine depleting agent.14,15 Under both 
of these conditions,   independent stimulation of either D1 or 
D2 receptors can elicit the full expression of DA-induced 
behaviors. This breakdown of synergism is invariably 
associated with profound supersensitivity of both D1 and 
D2 receptors. It is necessary to consider that the increase in 
DA receptor sensitivity is not necessarily correlated to an 
increase in DA receptor density, a phenomenon known as 
DA receptor   dissociation. Moreover, the D1/D2 synergism is 
independent of D1 and D2 receptor density.15
Ras homolog enriched in striatum (Rhes) protein is a 
novel striatal specific Ras-like small G protein very similar 
to Dexras-1.16 Rhes proteins are expressed in different areas 
of the central nervous system, but mainly in the striatum and 
olfactory tubercle.16–18 In addition, Rhes mRNA is particularly 
enriched in brain regions that receive dopaminergic inputs, 
such as the Striatum and Nucleus Accumbens.17 Rhes mRNA 
is also found in low to moderate levels in other areas of 
the nervous system, such as the cerebellum, thalamus, 
  hippocampus, and olfactory bulb during the early stages 
of postnatal development.17,19 Rhes mRNA in mammalian 
brains is   localized in D1R and D2R bearing striatal projection 
  neurons.20 In rodents, the modulation of Rhes protein 
expression in the basal ganglia depends mainly on thyroid 
hormone levels during early stages of development, but 
depends on dopamine levels and DA innervations during 
the adult stages.16,19
In general, there is a consensus that Rhes proteins could 
directly modulate the activation of the heterotrimeric G 
proteins to which G protein-coupled receptors (GPCRs) are 
coupled.21,22 Vargiu et al proposed possible   explanations 
for the mechanism of interaction between Rhes and GPCR, 
and the inhibitory effect of activated D2 receptor on cyclic 
  adenosine monophosphate (cAMP).18 This study also 
reported that Rhes proteins exert their effects by interacting 
with G-alpha inhibitory proteins (Gα/i).
Previous studies have shown that decreases in mRNA 
levels occur after manipulations of the dopaminergic system 
of the basal ganglia in adult animals (eg, DA depletion by 
6-OHDA or reserpine treatment), which results in conse-
quent dopamine receptor supersensitivity and breakdown of 
the D1/D2 receptor synergism.17 Rhes protein levels are also 
decreased under similar conditions of dopamine receptor 
supersensitivity and the breakdown of D1/D2 synergism.17
In striatum, there is a relationship among the expression 
of Rhes proteins, the degree of DA receptor sensitivity, D1/D2 
synergism, and the levels of dopamine neurotransmitters. 
Conditions that result in the breakdown of D1/D2 synergism 
and DA receptor supersensitivity (ie, DA depletion by 
6-OHDA or reserpine treatment) invariably cause a decrease 
in Rhes mRNA levels in the striatum.17 Possible mechanisms 
by which Rhes protein levels affect DA receptor signaling 
have been proposed. Errico et al reported that in mutant mice, 
a decrease in Rhes proteins results in D1R increased cAMP/
protein kinase A (PKA) signaling mediated by G-olfactory 
(olf) proteins, and decreased coupling efficiency of D2 
receptor to its downstream Gi/o proteins.20 Another study by 
Harrison et al added that Rhes proteins physically   interact 
with Gα/i and can interfere with adenylyl cyclase (AC) 
activation by the G-olf coupled D1 receptor in a pertussis 
toxin (PTX)-sensitive manner.23 Furthermore, Thapliyal et al 
reported that Rhes proteins inhibit N-type calcium channels, 
but decrease the ability of ligands for Gi/o-coupled receptors 
to inhibit these channels, an effect mediated by β-γ subunits 
released from PTX-sensitive G proteins.24
At a more behavioral level, the striatal Rhes protein has 
been linked to the inhibition of dopamine mediated behaviors 
in Rhes knockout (KO) mice. For instance, Rhes KO males 
denoted enhanced stereotypy after dopamine drug agonism.25 
Furthermore, Rhes knockout mice exhibited a higher D2 
receptor antagonist-induced catalepsy than Rhes wild type 
(WT) mice.20
Other behavioral studies by Errico et al reported that Rhes 
KO mice displayed hyperactivity and increased locomotor 
response in the novelty-induced exploration task and open 
field test, respectively.20 However, no differences were found 
between KO and WT mice in prepulse inhibition on their 
startle reflex, nor in motor coordination in the acelerating 
rotarod paradigm test. Furthermore, SKF 81297, a full D1R 
agonist, produced a higher enhancement of basal levels of 
activity in Rhes KO compared to their WT counterparts at 
doses of 1.5 mg/kg and 5 mg/kg.20 On the other hand, D1R 
agonist SKF 38393 induces less of an increase in grooming 
behavior in Rhes mutant mice compared to their WT 
counterparts.25
In addition, the postsynaptic D2R-like antagonist haloperi-
dol induced higher cataleptic behavior in Rhes KO compared 
to WT mice at all doses (0.25, 0.5, and 1.5 mg/kg). However, 
it seems that Rhes protein levels do not affect presynaptic 
D2R functioning as evaluated by locomotor responses to 
quinpirole at different doses as there were no differences 
between WT and KO mice. In summary, Errico et al’s 
behavioral studies concluded that Rhes protein levels act by 
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dopamine receptors transmission, and that decreasing Rhes 
protein levels facilitates the motor stimulation induced by a 
D1R agonist and strengthens the cataleptic response induced 
by the administration of a D2R antagonist.20
Another preliminary study by Spano et al showed that 
Rhes KO mice displayed a sex dependent increase in anxiety 
levels, deficits in motor coordination, while learning and 
memory processes remained unchanged.26 The present study 
evaluated whether or not there were sex related   differences 
in the behavioral effects of Rhes protein levels on   dopamine 
mediated behaviors, and assesses in both sexes the hypothesis 
that Rhes protein levels are causally related to the state 
of D1/D2 synergism and the degree of D1 and D2 receptor 
sensitivity.
Materials and methods
Subjects
In the present study, we used Rhes mutant mice of both sexes 
that had been backcrossed for ten generations on C57/Bl6 
background, and bred at the University of New Orleans.26 
Mice employed were 2 to 3 months old, and divided in 
3   genotypes: WT, KO, and heterozygous (Het). The number 
of mice totaled 58; 26 females (n $ 8, per genotype group), 
and 32 males (n $ 9, per genotype group). The mice were 
kept in same sex cages, in groups, with free access to food 
and water. Artificial lighting was provided from 7:00 am to 
7:00 pm. The present study followed the guidelines of the NIH 
regarding the care and use of animals for experimental proce-
dures, and the guidelines of the Institutional Animal Care and 
Use Committee (IACUC) of the University of New Orleans. 
Every effort was performed to minimize animal discomfort 
and to reduce the number of animals used. For controlling pain 
levels, mice were deeply anesthetized with intraperitoneal (IP) 
injections of tribromoethanol (100–150 mg per 10 g of body 
weight) for the tail biopsy procedures.
Open field (basal levels of activity  
and anxiety)
To determine whether the presence or absence of Rhes protein 
levels plays a role in basal levels of activity and anxiety, mice 
were placed in an open field arena (43.2 cm long by 33 cm 
wide by 32 cm high) for 30 minutes, for 5 consecutive days. 
During the test, the distance traveled in the arena field and 
the time spent in the periphery of the open field (thigmotaxis) 
were recorded by a digital video camera (Sony Corporation 
of America, New York, NY) and the video signal was sent 
directly to a computerized   behavior analysis system (SMART 
System, Harvard Apparatus, Holliston, MA). The time the 
mice spent in thigmotaxis was used as an index of anxiety. 
The periphery and center of the arena was defined as: the 
total area of the arena (1426 cm2) divided in two concentric 
rectangles (two areas of 713 cm2) with sides parallel to the 
arena limits. Thus, the total area of the arena was divided into 
2 equal parts (center and outside) with the same probability 
of being occupied.
Stereotypy test
We tested whether Rhes protein levels affected D1/D2 syner-
gism and DA receptor sensitivity by measuring stereotypy 
in response to dopaminergic drug administration. Stereotypy 
was used since it is a well characterized behavioral measure 
of D1/D2 synergism.27
Species-specific stereotyped behavior was recorded 
under each of the four following conditions: (1)   stimulation 
of neither receptor subtype (two saline injections at the 
  scheduled time points), (2) stimulation of both D1 and D2 
receptors [injection of saline 30 minutes prior to   injection 
of the mixed D1/D2 agonist apomorphine (3 mg/kg)], 
(3)   stimulation of D2 receptors alone [injection of the D1 
  antagonist SCH 23390 (0.1 mg/kg) 30 minutes prior to an 
injection of apomorphine (3 mg/kg)], (4) stimulation of 
D1 receptors alone [injection of the selective D2 antago-
nist eticlopride (0.3 mg/kg) 30 minutes prior to injection 
of apomorphine (3.0 mg/kg)]. All injections were IP, 
and every mouse was subjected to all conditions using 
a Latin square design in four sessions, each separated 
by 72–96 hours. This treatment regimen was used rather 
than selective agonists in order to eliminate the effects of 
endogenous DA at the heterotypic receptor. Each mouse 
was placed in a Plexiglas cylinder (measuring 22 cm high 
and 10.2 cm in diameter) with a thin layer of wood chip 
bedding on the floor. After 30     minutes of habituation, the 
appropriate pretreatment injection was given, followed 
30 minutes later by an injection of apomorphine or saline. 
The testing session was terminated 60   minutes later. 
Behavior was recorded with a Sony digital video camera 
for subsequent analysis and rated on a scale of 0 to 5 every 
5 minutes during a 30 second observation period. The 
behavioral analyst was blind to the genotype or pharma-
cological treatment. This rating scale, which was modified 
for mice from a similar study in rats, has been previously 
employed in other mutant mouse studies and is defined 
as follows: 0 = still; 1 = grooming or normal exploration; 
2 =   discontinuous unfocused stereotypy (eg, brief episodes 
of strong   sniffing); 3 = continuous unfocused stereotypy 
behavior (ie, stereotypy directed to multiple objects and/or Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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surfaces); 4 = continuous focused sniffing (ie, sniffing 
of one object or within a highly circumscribed area); 
5 =   continuous focused oral stereotypy (ie, licking/chewing 
of one object or within a highly circumscribed area).15,27 
Evaluation of the D1 receptor behavior was described 
in a previous related work.25 Specifically, grooming in 
response to the D1 agonist SKF 38393 was observed. Male 
mice were placed in Plexiglas cylinders for 30 minutes of 
habituation, then mice received an injection of SKF 38393 
(10 mg/kg, IP), and returned to the testing cylinders, and 
their behavior was recorded for the next hour. The amount 
of grooming (total seconds spent grooming every 5 minutes 
during a 60 second observation period) was recorded by 
an experimenter unaware of genotype.
Statistical analysis
Statistical analysis was performed using Analysis of Variance 
(ANOVA) factorial with post hoc tests. Significance was set at 
P value of ,0.05. IBM SPSS Statistics (v 19; Armonk, NY) 
for Windows program was employed for statistical analysis. 
The numerical values described in the Results section repre-
sent the Mean ± Standard Error of the Mean (SE).
Results
The data for all the behavioral experiments were analyzed 
by a mixed repeated measures design with the IBM SPSS 
Statistics 19 for Windows. Table 1 shows a general summary 
of experimental data for all behavioral tests.
Basal levels of activity
Figure 1 shows locomotion traveled distance across 5 days 
(30 minutes per day). Mixed repeated measures ANOVA 
of traveled distance showed significant main effect of 
days (Wilks’ Lambda: 0.8, F (4, 64) = 5.2, P , 0.01), a 
significant main effect of genotype (Wilks’ Lambda: 0.8, 
F (8, 128) = 2.3, P , 0.02), and significant main effect of 
sex (Wilks’ Lambda: 0.9, F (4, 64) = 2.6, P , 0.05), but a 
nonsignificant days × genotype × sex interaction (Wilks’ 
Lambda: 0.9, F (8, 128) = 1.1, P = 0.4). Subsequent analysis 
of the main effect of days with t student comparisons revealed 
that the distance traveled on day 1 (7425.7 cm ± 184.6) 
was   significantly different from distances traveled on 
day 2 (7167.0 cm ± 172.3), day 4 (7296.2 cm ± 165.4), and 
day 5 (7594.8 cm ± 170.9). The distance traveled on day 3 
(6986.9 cm ± 143.2) also differed from the distance traveled 
on day 5 (7594.8 cm ± 170.9) (P , 0.001, all contrasts). 
Further analysis of the main effect of genotype with t student 
comparisons revealed that WT mice (7848.8 cm ± 269.2) 
displayed higher levels of activity compared to Het mice 
(7053.7 cm ± 312.6) on day 1 (t (16) = 2.6, P , 0.02); 
however, WT mice (6489.7 cm ± 236.9) showed lower 
levels of activity than KO mice (7220.1 cm ± 182.4) 
on day 3 [t (20) = -2.2, P , 0.05]. On day 5, KO mice 
(8160.1 cm ± 372.6) exhibited higher levels of activity than 
Het mice (7280.9 cm ± 156.7) (t (22) = -2.8, P , 0.02). 
On the other hand, further analysis of the main effect of sex 
with t   student comparisons was unable to reveal significant 
  differences between males and females on any of the five 
days (P . 0.05). In general, the locomotion tests showed that 
variation in Rhes protein levels could be related to variation 
in the levels of activity, but this trend could vary across days 
of exposition to the open field.
Figure 2 shows locomotion-traveled distance in the first 
15 minutes of day 1. Mixed repeated measures design of 
traveled distance showed a significant effect of time (Wilks’ 
Lambda: 0.8, F (2, 55) = 8.8, P , 0.001), a   nonsignificant 
effect of genotype (Wilks’ Lambda: 0.9, F (4, 110) = 0.7, 
P = 0.6), a nonsignificant effect of sex (Wilks’ Lambda: 0.9, F 
(2, 55) = 0.3, P = 0.7), and a significant time ×   genotype × sex 
interaction (Wilks’ Lambda: 0.8, F (4, 110) = 2.8, P = 0.03). 
Subsequent analysis of the effect of time with t student 
comparisons did not find a significant difference between 
groups. Compared to Spano et al’s results, our results did not 
show significant differences between genotypes; however, 
Rhes Het mice exhibited lower levels of activity compared 
to WT mice in the first 10 minutes, and Spano et al’s results 
Table 1 Data summary
Locomotion activity  
Distance traveled (cm)
Anxiety  
Thigmotaxis (sec)
Stereotypy  
Stereotypy scores
Day Mean SE Day Mean SE Treatment Mean SE
1 7425.7 184.6 1 1105.9 27.3 condition
2 7167 172.3 2 1198.3 26.2 Saline 0.7 0.0
3 6986.9 143.2 3 1162.2 26.9 D1 0.2 0.0
4 7296.2 165.4 4 1230.6 29.4 D2 0.6 0.1
5 7594.8 170.9 5 1205.5 28.3 D1 + D2 2.0 0.1
Abbreviations: sec, seconds; Se, standard error.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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reported that KO mice showed lower levels of activity than 
their WT counterparts in the first 5 minutes (however, the 
main effects in that were not significant).26 Taking together 
this study’s and Spano et al’s previous results, it could be 
interpreted as Rhes protein level reduction is related to 
some decrease in basal levels of activity. Also, differences 
between both studies could be explained by differences in 
sampling.
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Anxiety
Figure 3 shows time spent in thigmotaxis across 5 days 
(30 minutes per day). Mixed repeated measures design 
for thigmotaxis time showed a significant main effect of 
days (Wilks’ Lambda: 0.7, F (4, 64) = 5.6, P , 0.01), a 
nonsignificant main effect of genotype (Wilks’ Lambda: 
0.8, F (8, 128) = 1.7, P = 0.09), a nonsignificant main effect 
of sex (Wilks’ Lambda: 0.9, F (4, 64) = 0.9, P = 0.4), and 
a nonsignificant day × genotype × sex interaction (Wilks’ 
Lambda: 0.8, F (8, 128) = 1.6, P = 0.1). Subsequent analysis 
of the main effect of days with t student comparisons revealed 
that thigmotaxis in day 1 (1105.9 sec ± 27.3) was signifi-
cantly   different from the rest of the days: day 2 (1198.3 sec ± 
26.2), day 3 (1162.2 sec ± 26.9), day 4 (1230.6 sec ± 29.4), 
and day 5 (1205.5 sec ± 28.3) (P , 0.001, all contrasts). 
Despite the fact that the genotype main effect was not 
  significant, there was a marked trend (P = 0.095) that a 
decrease in Rhes protein levels was related to lower levels of 
anxiety (lower time in thigmotaxis) (WT: 1198.5 sec ± 42.8, 
KO: 1133.0 sec ± 46.4, Het: 1136.8 sec ± 41.8).
Stereotypy
Figure 4 shows stereotypy scores averaged across the 
60   minute observation period. Mixed repeated measures 
design of stereotypy scores showed significant main effects of 
treatment (Wilks’ Lambda: 0.1, F (3, 51) = 240,3, P , 0.001), 
genotype (Wilks’ Lambda: 0.7, F (6, 102) = 4.1, P , 0.001) 
and sex (Wilks’ Lambda: 0.8, F (3, 51) = 3.1, P = 0.04), but a 
nonsignificant treatment × genotype × sex interaction (Wilks’ 
Lambda: 0.9, F (6, 102) = 0.7, P = 0.6).
Concomitant analysis of the main effect of treatment 
with t student comparisons revealed that D1 + D2 treatment 
(2.0 ± 0.1) revealed significantly higher stereotypy scores 
compared to the rest of the treatments [saline (0.7 ± 0.0), 
D1 (0.2 ± 0.0), and D2 (0.6 ± 0.1)]; moreover, t student’s 
comparisons also revealed that D1 treatment (0.2 ± 0.0) was 
significantly different from saline (0.7 ± 0.0) and D2 treat-
ment (0.6 ± 0.1) (P , 0.001, all contrasts). This suggests that 
D1 + D2 treatment varied significantly from saline, D1, and 
D2 treatment conditions, signifying that Rhes protein levels 
do not influence D1/D2 synergism.
Subsequent analysis of the main effect of genotype with t 
student comparisons revealed that under D1 agonism treatment 
conditions, the WT group had (0.3 ± 0.0) higher stereotypy 
scores compared to the KO (0.1 ± 0.0) and Het groups 
(0.1 ± 0.0) (P , 0.001, all contrasts); furthermore, t students 
comparisons also revealed that under D1 + D 2 treatment 
condition the WT group (1.7 ± 0.1) showed lower levels of 
stereotypy compared to KO (2.2 ± 0.2) and Het (2.2 ± 0.2) 
groups, but these differences did not reach significant levels 
(P = 0.06 and P = 0.11, respectively).   Furthermore, the 
analysis of the main effect of sex with t student comparisons 
0
300
600
900
1200
1500
12345
Day
T
i
m
e
 
s
p
e
n
t
 
i
n
 
p
e
r
i
p
h
e
r
y
 
(
s
e
c
s
)
m
e
a
n
 
±
 
S
E
Female WT Female KO
Female Het Male WT
Male KO Male Het 
Figure 3 Profile of anxiety behavior in female and male WT, KO, and Het mice in the open field. 
Notes: Every bar represents the mean time in seconds spent in the periphery of the open field (±Se). The total amount of time for screening the behavior per day was 
30 minutes (1800 seconds). 
Abbreviations: WT, wild type; KO, knockout; Het, heterozygous; SE, standard error.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
703
Sex differences in dopamine mediated behaviors
revealed that under D1 + D2 agonism treatment, the male group 
(2.2 + 0.1) showed higher levels of stereotypy compared to 
the female group (1.7 ± 0.1) (P = 0.05).
In synthesis some trends were evident in the effects of 
treatments: under D1 treatment condition, both KO and Het 
mice showed significantly lower stereotypy scores compared 
to WT mice. Furthermore, under D1 + D2 treatment, KO and 
Het mice showed a higher (nonsignificant) response than 
WT mice.
Discussion
The present results of the effects of Rhes protein levels in 
basal levels of activity are in partial agreement with previous 
similar behavioral studies. For instance, Spano et al reported 
in the open field that KO mice showed lower levels of activ-
ity in the first 5 minutes of the open field (15 minute test) 
compared to WT mice.26 In our study, the open field test was 
performed for 30 minutes for 5 consecutive days, however, 
we included an additional analysis of the data as performed 
by Spano et al (15 minutes of day 1, Figure 2); this analysis 
denoted that Het mice showed lower levels of activity than 
their WT counterpart, but the tendency was not significant. 
It is important to consider that Spano et al’s study reported 
a significant post hoc effect despite the absence of a main 
significant effect.26 However, both studies agreed that a 
decrease in Rhes protein levels could be associated with a 
decrease in basal levels of activity.
Another study by Errico et al explored basal levels of 
activity in Rhes mutant mice. They reported that KO mice 
expressed higher rather than lower levels of activity compared 
to WT mice in the last 20 minutes of the open field test 
(30 minute session).20 In the present study, KO mice also 
showed higher levels of activity than WT mice but only on 
the third day of the test. In this sense, both studies agree that 
a reduction in Rhes protein levels is related to an increase in 
basal levels of activity. The hyperactivity of the Rhes mutant 
mice can be explained by the control exerted by Rhes protein 
levels on G-olf protein levels, which are expressed higher in 
striatum of Rhes KO mice compared to their WT counterparts 
(KO mice expressed 114% to 124% of WT mice levels), 
according to Errico et al.20
The present study found a marked but not significant 
association between a decrease in Rhes protein levels and 
anxiolysis; KO and Het mice showed lower levels of anxiety 
compared to their WT counterparts, a tendency that was more 
marked in female mice (shown in Figure 3). Our results in 
anxiety differ from those obtained by Spano et al.26 Those 
authors found higher levels of anxiety in the female KO mice 
compared to their WT counterpart, while our study found the 
opposite tendency: KO mice displayed significantly lower 
levels of anxiety. This discrepancy could be explained by 
differences in the number of subjects employed and the type 
of anxiety test. Spano et al’s study used the elevated plus 
maze test rather than the open field test. As a reference, other 
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Moreover, D1 Treatment differed significantly from the rest of the Treatments (P , 0.001). **P , 0.001 WT groups differs from KO and HET; *P , 0.01 male WT groups 
differs from male KO and HET.
Abbreviations: WT, wild type; KO, knockout; Het, heterozygous; SE, standard error.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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mutant models of anxiety, such as the Galanin R1 receptor 
(GAL-R1), have also found inconsistent results between the 
elevated plus maze and open field tests.28 In general, despite 
the apparent discrepancies between our study and Spano 
et al’s study, one commonality is that female KO mice dif-
fer from WT and Het mice on anxiety levels, an effect that 
should be explored further.26
Different authors have pointed out relationships 
between DA receptor dynamics and anxiety states. For 
instance, different authors have reported that lower doses 
of apomorphine (an agonist of D1 and D2 receptors) have 
sedating, relaxing and anxiolytic effects.29–33 Moreover, 
imaging studies (PET) have shown marked relationships 
between central D2 receptor density, DA synthesis capacity 
in the striatum, and neuroticism anxiety (an intense feeling 
of anxiety, disproportionate to the trigger and can actually 
interfere with an individual’s ability to function normally).34,35 
In general, other studies have proposed a relevant role of DA 
in the genesis and treatment of anxiety states.36 A possible 
explanation that can be drawn from the study is that because 
Rhes protein levels influence DA receptor supersensitivity, 
then an increase in DA receptor sensitivity is related to an 
anxiolytic effect, mainly in female mice.17 Moreover, a 
clinical study reported that dopamine receptor density could 
affect anxiety conditions.37 In effect, that study reached a 
consensus that sex differences of neuroticism-anxiety related 
to variations in D2 receptor density exist; it reported a sex 
specific (male but not female) association between lower 
neuroticism-anxiety and the expression of the A1 + allele 
of the DRD2 Taq 1 polymorphism (lower levels of anxiety 
correlated to lower levels of D2 receptor density). Then, 
if there were associations between dopamine receptor 
density and anxiety, even sex specific relationships, then 
the existence of relationships between dopamine receptor 
sensitivity and anxiety should also be possible.
Our present results in the stereotypy test suggest a sex 
difference in the response to apomorphine; males showed 
higher levels of stereotypy response compared to females. 
Other similar studies in rodents have found different results; 
for instance, it has been reported that females display higher 
levels of apomorphine and cocaine-induced stereotypy than 
males.38,39 A possible explanation for this difference is due 
to levels of estrogen in females.40 Female rats in estrus (high 
estrogen level) display low levels of stereotypy; furthermore, 
males treated with estrogen display a lower level of stereo-
typy compared to their nontreated counterparts.40
The ovarian hormones effect on stimulants response is 
complex, and research results are contradictory.41 Some   studies 
found no effect of ovariectomy in   amphetamine-induced 
stereotypy.38,42 However, other studies have found larger 
effects of cocaine and amphetamine in stereotypy under the 
estrus phase.43,44
The decrease in Rhes protein levels does not seem to 
affect D1/D2 synergism, because D1 agonism and D2 agonism 
treatments induced lower stereotypic responses compared to 
D1 + D2 agonism treatment in KO and Het mice. If D1/D2 syn-
ergism were broken, then D1 or D2 agonism treatments should 
generate a higher stereotypic response, similar to D1 + D2 
agonism treatment. Furthermore, KO and Het mice showed 
lower stereotypic responses under D1 treatment compared to 
their WT counterparts, suggesting that Rhes protein levels 
are facilitatory of D1 mediated behaviors. This is also sup-
ported by previous results published by our group reporting 
that Rhes protein levels appear to facilitate D1-  specific 
grooming behaviors in males.25 Our results suggest that 
Rhes protein levels are inhibitory of behaviors mediated 
by D1 + D2 receptor co-stimulation. A possible explanation 
for the difference between the facilitatory effect of Rhes 
proteins on D1 agonism behavior and the inhibitory effect on 
D1 + D2 agonism behavior could be linked to a previous result 
by Errico et al. They reported that the mutant mice model 
that decreases Rhes protein levels results in a D1R increased 
cAMP/PKA signaling which is mediated by G-olf proteins, 
and a decreased coupling efficiency of the D2 receptor to its 
downstream Gi/o proteins.20 Our previous work with a group 
of male mice reported a significant difference between KO 
and Het mice compared to WT mice under D1 + D2 treatment. 
In the present study, female groups did not show the same 
trend as male groups, and this could explain the differences 
in trends when both sexes were combined.25
The present results suggest that Rhes proteins do not 
seem to be indispensable for DA D1/D2 receptor synergism 
in both sexes. However, Rhes proteins exert intricate effects 
on D1 and D2 receptor sensitivity. Specifically, Rhes proteins 
suppress behaviors generated by combined agonism of D1 and 
D2 receptors, mainly in male mice (Figure 4). The modulatory 
effects on D1 receptors are more intricate as well. Although 
it has been shown previously to be inhibitory to GαS activa-
tion and Gα-olf expression, its presence is necessary for full 
expression of the D1-mediated grooming behavior. Despite 
the fact that Rhes protein levels do not seem to affect DA 
synergism, they do affect the sensitivity of the response to 
DA receptor activation. The increased response to D1 + D2 
receptor co-activation by apomorphine in male but not in 
female KO mice suggests that Rhes proteins are repressive 
of this response and a potential sex difference. Other   studies Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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performed in Rhes mutant mice suggest a repressive role 
for Rhes proteins in DA-mediated events. For example, 
Rhes KO mice show an increased locomotor response to 
the D1 agonist SKF 81297, and increased Gα-olf levels and 
Glutamate R1 phosphorylation.20 In a heterologous expres-
sion system, Rhes protein levels were shown to inhibit the 
activation of GαS-coupled receptors at a point proximal to 
G protein activation.18 The results for D2 receptor activation 
are less clear, with KO mice showing reduced D2-mediated 
G protein activation and increased sensitivity to D2 antago-
nists.20 Our results indicate that for stereotypy, a behavior 
elicited only by concomitant stimulation of D1 and D2 recep-
tors, Rhes proteins are inhibitory mainly in male mice rather 
than female mice.
To elucidate the effects of Rhes on activation of D1 and D2 
receptors independently, we tested behavior induced by each 
receptor subtype alone. Agonism of D1 receptors did not induce 
stereotypy, but the scores on the rating scale were reduced in 
KO and Het mice compared to their WT counterparts in both 
sexes. This effect is probably linked to an enhanced sensitivity 
to the D2 antagonist eticlopride, which was administered prior 
to apomorphine in the D1 group, and is in agreement with the 
findings of Errico et al, who reported increased catalepsy to 
haloperidol treatment in KO mice.20 Activation of D2 recep-
tors did not induce significant differences in stereotypy among 
experimental groups for both sexes.
As in all experiments using mice in which a gene is 
knocked-out from the single cell stage, interpretations of the 
present results require caution. This model of mutant mice 
is limited by potential genetic compensatory responses that 
could lead to anatomical and physiological compensations 
during development. Subsequent studies could explore 
the present findings with a knockout model in which the 
knocking out condition is restricted in time, for example, to 
adulthood (temporal conditional knockout), or restricted in 
space; for instance, limited to the striatum.
Conclusion
In conclusion, the present research shows that changes in 
Rhes protein levels affect basal levels of activity and ste-
reotypy response under DA receptor agonism conditions; 
furthermore, a decrease in Rhes protein levels could be linked 
to anxiolysis in females. A decrease in Rhes protein levels 
does not affect D1/D2 synergism in female and males.
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